Mathias et al. (58) investigated the role of LINC01871 in 5 molecular subtypes of breast cancer and found that LINC01871 is associated with immune response activation and favorable OS in patients with basal-like breast cancers. This evidence concerns the gene LINC01871 and breast cancer.